Verfasser: |
Degre, D
Serste, T
Lasser, L
Delwaide, J
Starkel, P
Laleman, W
Langlet, P
Reynaert, H
Bourgeois, S
Vanwolleghem, Thomas
Dastis, SN
Gustot, T
Geerts, A
Van Steenkiste, C
De Galocsy, C
Lepida, A
Orlent, H
Moreno, C |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2017 |
Reihe/Periodikum: |
Degre , D , Serste , T , Lasser , L , Delwaide , J , Starkel , P , Laleman , W , Langlet , P , Reynaert , H , Bourgeois , S , Vanwolleghem , T , Dastis , SN , Gustot , T , Geerts , A , Van Steenkiste , C , De Galocsy , C , Lepida , A , Orlent , H & Moreno , C 2017 , ' Sofosbuvir in Combination with Simeprevir plus /- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium ' , PLoS One (print) , vol. 12 , no. 1 , e0170933 . https://doi.org/10.1371/journal.pone.0170933 |
Schlagwörter: |
/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
/ SDG 3 - Good Health and Well-being |
Sprache: |
unknown |
Permalink: |
https://search.fid-benelux.de/Record/base-28554489 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/b6cc46be-ecbc-41c2-a155-dfb56d11c408 |